ISF College of Pharmacy B.Pharm (Lateral Entry) FAQs
Ques. What is the fee for B.Pharm Lateral Entry at ISF College of Pharmacy, Moga?
Ans. The total fee for the three-year B.Pharm Lateral Entry programme at ISFCP, Moga is INR 2,70,000, charged at INR 45,000 per semester across six semesters (Semesters 3 to 8). University examination and registration fees are payable separately. Hostel charges of INR 60,000 to 90,000 per year are not included.
Ques. Who is eligible for B.Pharm Lateral Entry at ISFCP, Moga?
Ans. Candidates who hold a Diploma in Pharmacy (D.Pharm) from a PCI-recognised and AICTE-approved institution with a minimum of 50 per cent aggregate marks are eligible for lateral entry. Lateral entry students join directly in the second year (Semester 3) and complete three years to earn the full B.Pharm degree.
Ques. How does B.Pharm Lateral Entry differ from regular B.Pharm?
Ans. Regular B.Pharm is a four-year (eight-semester) programme starting from Semester 1, open to 10+2 PCM or PCB candidates. B.Pharm Lateral Entry is a three-year (six-semester) programme starting from Semester 3, open exclusively to D.Pharm holders. Both programmes result in the same B.Pharm degree from IKGPTU and carry equivalent professional recognition.
Ques. What career options are available after B.Pharm Lateral Entry from ISFCP, Moga?
Ans. B.Pharm Lateral Entry graduates from ISFCP, Moga are eligible for drug inspector roles in state government, pharmaceutical manufacturing and QA/QC positions, hospital and clinical pharmacy roles, regulatory affairs positions, and community pharmacy practice. The B.Pharm degree also qualifies graduates to apply for M.Pharm, Pharm.D (Post-Baccalaureate), or MBA (Pharma) programmes.
Ques. Is B.Pharm Lateral Entry recognised by the Pharmacy Council of India?
Ans. Yes. The B.Pharm Lateral Entry programme at ISFCP, Moga is approved by the Pharmacy Council of India (PCI) and AICTE, following the PCI’s norms for lateral entry from D.Pharm to B.Pharm. The degree awarded by IKGPTU is recognised for employment in pharmacy, drug regulatory, and healthcare roles across India.







Comments